Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by TheRock07on Aug 09, 2016 8:48pm
253 Views
Post# 25124689

RE:You're clearly not a bunch of intellectual dynamos, are you?

RE:You're clearly not a bunch of intellectual dynamos, are you?As a going-forward strategy and in conjunction with the planned acquisition of a mental-health-care-billing software company, Inspira will focus on highly profitable revolving lines of credit up to $5-million primarily lending to companies in the mental health and substance abuse industry with an additional focus of selling billing and financial software and services to its clients.

So, they have a more concentrated lending service which will now be enhanced with cross selling of their billing software company.

With that perspective , they are confident enough to begin a regular dividend and plan to increase that dividend consonant with increased future cash flows.

So, what's not to like unless you have a hangover .

And thanks for your unnecessary advice..
Bullboard Posts